Corporate Information

News & Events

San Antonio Breast Cancer Symposium, Henry B. Gonzalez Convention Center, San Antonio, TX

American Association for Cancer Research, McCormick Place, Chicago, IL

December 21, 2011
HistoRx Licenses Melanoma Assay from Yale University

November 17, 2011
AQUA® Technology Expands to Additional Digital Pathology Platform with Launch of Vectra™ 2 from Caliper Life Sciences, a Perkin-Elmer Company

October 24, 2011
CLARIENT JOINS THE HISTORX® CLINICAL TRIALS NETWORK: FIRST COMMERCIAL LAB TO PROVIDE AQUA® TECHNOLOGY FOR CLINICAL TRIALS

October 6, 2011
HISTORX EARNS TWO ADDITIONAL PATENTS ON STANDARDIZATION OF RESULTS FROM DIGITAL PATHOLOGY INSTRUMENTS

May 3, 2011
HISTORX ANNOUNCES LAUNCH OF NEW RESEARCH SERVICES: AQUAPrep™ AND Access AQUA® SERVICES NOW AVAILABLE

March 21, 2011
HISTORX RECEIVES FUNDAMENTAL PATENT ON STANDARDIZATION OF RESULTS IN DIGITAL PATHOLOGY

March 9, 2011
Caliper Life Sciences and HistoRx to Provide Integrated Solutions for Superior Protein Quantification of Biomarkers in Tissue

December 20, 2010
METAMARK AND HISTORX ANNOUNCE LICENSING AGREEMENT FOR AQUA® TECHNOLOGY

December 15, 2010
Jack Davis, Diagnostics Industry Executive, Joins the HistoRx Board of Directors

December 13, 2010
STUDY INDICATES MEASUREMENT OF ESTROGEN RECEPTOR BY AQUA® TECHNOLOGY PREDICTS RESPONSE TO RADIATION THERAPY IN BREAST CANCER

November 12, 2010
HISTORX ANNOUNCES FIRST CLINICAL DIAGNOSTIC USE OF AQUA® TECHNOLOGY

October 18, 2010
Heiner Dreismann, Ph.D., Former President of Roche Molecular Systems, Joins HistoRx Board of Directors

March 15, 2010
HistoRx Recognized as a 2010 Company to Watch by the Connecticut Technology Council

March 15, 2010
HISTORX RECEIVES KEY PATENT ON APPLICATION OF AQUA® TECHNOLOGY TO PERSONALIZED MEDICINE

March 15, 2010
Connecticut Innovations Provides Facilities Loan of $1.5 Million to HistoRx Inc.

February 19, 2010
GENOPTIX AND HISTORX ANNOUNCE LICENSING AGREEMENT FOR AQUA® TECHNOLOGY

January 19, 2010
HistoRx Names Dick Carroll, Ph.D. as VP of Clinical Research

December 3, 2009
Protein Markers Predict Risk of Melanoma Recurrence

November 17, 2009
AQUA® Technology Recognized as "Promising New Strategy" for Hormone Receptor Testing in Breast Cancer by NCCN Task Force

September 9, 2009
Aperio Partners with HistoRx to Provide Integrated Fluorescence Whole Slide Imaging System

December 17, 2008
HistoRx Names Kate Adams Vice President, Diagnostics Marketing and Retains Steve Chubb as Strategic Advisor

July 17, 2008
HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations

May 29, 2008
HistoRx Announces Expanded Access of AQUA® Technology to 900+ Researchers at Dana-Farber/Harvard Cancer Center

March 26, 2008
HistoRx and Lilly Extend, Expand AQUA® Analysis Partnership

November 27, 2007
HistoRx Names Rana Gupta CEO; Announces Board Changes

October 24, 2007
HistoRx Raises $6.0 Million in Series B Funding to Advance Diagnostic Product Development

September 4, 2007
HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership

May 16, 2007
HistoRx Announces Issuance of U.S. Patent Covering Core AQUA® Technology

February 22, 2007
HistoRx AQUA® Technology Identifies Two Biomarkers Linked to Lung Cancer Survival

February 15, 2007
HistoRx Installs AQUA® Technology at UCLA School of Medicine

October 24, 2006
HistoRx Announces First Installations of New Quantitative In Situ Biomarker Analysis Platform

January 31, 2006
HistoRx, Inc. Moves to Advance the Development and Commercialization of New Quantitative Tissue Based Diagnostic Tests

December 21, 2005
More Accurate, Quantitative Method Reported for Linking Biomarker Expression to Patient Outcomes

November 1, 2005
Dr. Ronald M. Lindsay Joins HistoRx Board of Directors

October 13, 2005
HistoRx and Eli Lilly Enter Into a Collaboration

July 25, 2005
High TRAIL-R2 Expression is Associated With Decreased Breast Cancer Survival

May 2, 2005
HistoRx Moves to State-of-the-Art R&D Complex

February 23, 2005
HistoRx to Unveil HARP™ Program

September 14, 2004
HistoRx Completes Initial Financing